N52K (p.Asn52Lys) variant of NCF2 (Neutrophil cytosol factor 2)

N52K (p.Asn52Lys) in NCF2 (Neutrophil cytosol factor 2) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.27 / 1. The record also includes population frequency data, experimental measurements, and structural context.

N52K (p.Asn52Lys) variant details